SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?


To: out_of_the_loop who wrote (567)5/9/1999 8:07:00 PM
From: Mike M  Respond to of 5582
 
The risk of dilution is not that great because the VALUE these men bring is huge. I hearby pronounce, "it's OK with me". <LOL>

Totally agree....This is not a give away, this is a tit for tat....the dilution is tiny by comparison to the impact of Zicam....and Gel Tech....

When the options expire is of little consequence and the $1.9M capital infusion will be helpful whenever it occurs....This is a win win...



To: out_of_the_loop who wrote (567)5/11/1999 4:10:00 PM
From: Mike M  Read Replies (2) | Respond to of 5582
 
The silence from this company is deafening....Anybody know when they will announce earnings this week? Speculation?